These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3320488)

  • 1. [Effect of diltiazem on blood cyclosporin levels].
    Kunzendorf U; Walz G; Neumayer HH; Wagner K; Keller F; Offermann G
    Klin Wochenschr; 1987 Nov; 65(22):1101-3. PubMed ID: 3320488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin-diltiazem interaction: comparison of cyclosporin levels measured with two monoclonal antibodies.
    Sabaté I; Griñó JM; Castelao AM; Huguet J; Serón D; Blanco A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1460-1. PubMed ID: 2652466
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic interaction between cyclosporin and diltiazem.
    Brockmöller J; Neumayer HH; Wagner K; Weber W; Heinemeyer G; Kewitz H; Roots I
    Eur J Clin Pharmacol; 1990; 38(3):237-42. PubMed ID: 2340843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A (CsA): pharmacokinetics, clinical monitoring and pharmacodynamics in bone marrow transplantation (BMT).
    Carreras Pons E
    Prog Clin Biol Res; 1989; 309():325-32. PubMed ID: 2675101
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary on therapeutic drug monitoring for renal transplantation.
    Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels.
    Alcaraz A; Oppenheimer F; Talbot-Wright R; Fernández-Cruz L; Mañalich M; García-Pagés E; Cetina A; Vendrell JR; Carretero P
    Transplant Proc; 1991 Oct; 23(5):2383-4. PubMed ID: 1926395
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.
    Kelly JJ; Walker RG; d'Apice AJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2127-8. PubMed ID: 2219318
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study.
    Wagner K; Albrecht S; Neumayer HH
    Am J Nephrol; 1987; 7(4):287-91. PubMed ID: 3318461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements.
    Kohlhaw K; Wonigeit K; Frei U; Oldhafer K; Neumann K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):572-4. PubMed ID: 3284105
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protective effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. The results of a prospective randomized study].
    Wagner K; Albrecht S; Neumayer HH
    Dtsch Med Wochenschr; 1986 Sep; 111(36):1363-7. PubMed ID: 3527645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cyclosporin and calcium antagonists.
    Wagner K; Philipp T; Heinemeyer G; Brockmüller F; Roots I; Neumayer HH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1453-6. PubMed ID: 2652465
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese conference on cyclosporine blood level monitoring.
    Takagi H; Uchida K
    Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
    [No Abstract]   [Full Text] [Related]  

  • 13. Elective conversion from cyclosporin to azathioprine in living related donor kidney transplants.
    Sobh MA; Eldein AB; Moustafa FE; Ghoneim MA
    Nephrol Dial Transplant; 1987; 2(4):258-60. PubMed ID: 3118269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of the determination of cyclosporin circulating levels].
    Clerico A; Zucchelli GC
    Minerva Med; 1992; 83(1-2):1-8. PubMed ID: 1545917
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 16. Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone.
    Uchida K; Orihara A; Yamada N; Tominaga Y; Kawai M; Tanaka Y; Morozumi K; Hayashi S; Satake M; Taira N
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):401-5. PubMed ID: 3279629
    [No Abstract]   [Full Text] [Related]  

  • 17. Diltiazem for hypertension and premature uterine contractions in a renal transplant recipient taking cyclosporin.
    Lechner W; Steurer W; Margreiter R
    Transpl Int; 1991 Apr; 4(1):62. PubMed ID: 2059302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preventive systemic cyclosporin A in risk keratoplasty].
    Rossa V; Sundmacher R; Heering P
    Klin Monbl Augenheilkd; 1990 Dec; 197(6):466-9. PubMed ID: 2087048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
    Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
    [No Abstract]   [Full Text] [Related]  

  • 20. [14 years of kidney transplantation in children. Results with special reference to cyclosporin A treatment].
    Brodehl J; Pichlmayr R; Offner G
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):771-3. PubMed ID: 3906380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.